Wave Life Sciences Ltd. (WVE)
6.245
+0.10
(+1.71%)
USD |
NASDAQ |
May 20, 13:11
Wave Life Sciences EPS Diluted (Quarterly) : -0.1303 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| Eli Lilly & Co. | 8.255 |
| GSK Plc | 1.149 |
| Jazz Pharmaceuticals Plc | 4.434 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.09M |
| Revenue (Quarterly) | 38.25M |
| Total Expenses (Quarterly) | 64.33M |
| Enterprise Value | 652.34M |
| Gross Profit Margin (Quarterly) | 93.97% |
| Profit Margin (Quarterly) | -68.21% |
| Earnings Yield | -16.88% |
| Normalized Earnings Yield | -16.88 |